Company Encyclopedia
View More
name
Bio-Techne
TECH.US
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids.
770.48 B
TECH.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking24/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.80%C
    • Profit Margin6.41%B
    • Gross Margin66.37%A
  • Growth ScoreC
    • Revenue YoY3.85%C
    • Net Profit YoY-48.27%D
    • Total Assets YoY-7.67%D
    • Net Assets YoY-8.08%D
  • Cash ScoreB
    • Cash Flow Margin1560.95%B
    • OCF YoY3.85%C
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreA
    • Gearing Ratio22.18%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More
    Posts
    View More

    $AT & T(T.US)rump Media & Tech.US Haven't kept an eye on it for a while, and I was taken aback when I checked. Can't claim to understand it—just feel it's time to exit.

    XPeng 3Q25 Quick Interpretation: The "slightly cold" car sales business meets the hot AI expectations.

    Due to XPeng's recent updates on AI advancements during last week's Tech Day, the stock price has...